These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18513382)

  • 1. A computerized infusion pump for control of tissue tracer concentration during positron emission tomography in vivo pharmacokinetic/pharmacodynamic measurements.
    Eriksson O; Wallberg A; Syvänen S; Josephsson R; Långström B; Bergström M
    BMC Med Phys; 2008 May; 8():2. PubMed ID: 18513382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography and target-controlled infusion for precise modulation of brain drug concentration.
    Eriksson O; Josephsson R; Långstrom B; Bergström M
    Nucl Med Biol; 2008 Apr; 35(3):299-303. PubMed ID: 18355685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle.
    Lassen NA; Bartenstein PA; Lammertsma AA; Prevett MC; Turton DR; Luthra SK; Osman S; Bloomfield PM; Jones T; Patsalos PN
    J Cereb Blood Flow Metab; 1995 Jan; 15(1):152-65. PubMed ID: 7798333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier penetration of zolmitriptan--modelling of positron emission tomography data.
    Bergström M; Yates R; Wall A; Kågedal M; Syvänen S; Långström B
    J Pharmacokinet Pharmacodyn; 2006 Feb; 33(1):75-91. PubMed ID: 16402287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors.
    Gründer G; Siessmeier T; Lange-Asschenfeldt C; Vernaleken I; Buchholz HG; Stoeter P; Drzezga A; Lüddens H; Rösch F; Bartenstein P
    Eur J Nucl Med; 2001 Oct; 28(10):1463-70. PubMed ID: 11685488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lorazepam [7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one] occupancy of rat brain gamma-aminobutyric acid(A) receptors measured using in vivo [3H]flumazenil (8-fluoro 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester) binding and [11C]flumazenil micro-positron emission tomography.
    Atack JR; Scott-Stevens P; Beech JS; Fryer TD; Hughes JL; Cleij MC; Baron JC; Clark JC; Hargreaves RJ; Aigbirhio FI
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1030-7. PubMed ID: 17164474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge.
    Zhou Y; Chen MK; Endres CJ; Ye W; Brasić JR; Alexander M; Crabb AH; Guilarte TR; Wong DF
    Neuroimage; 2006 Nov; 33(2):550-63. PubMed ID: 16920365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates.
    Tomasi G; Nabulsi N; Zheng MQ; Weinzimmer D; Ropchan J; Blumberg L; Brown-Proctor C; Ding YS; Carson RE; Huang Y
    J Nucl Med; 2013 Apr; 54(4):600-8. PubMed ID: 23424192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusion.
    Pinborg LH; Ziebell M; Frøkjaer VG; de Nijs R; Svarer C; Haugbøl S; Yndgaard S; Knudsen GM
    J Nucl Med; 2005 Jul; 46(7):1119-27. PubMed ID: 16000280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Infusion Schemes for Neuroreceptor Imaging: Application to [(11)C]Flumazenil-PET Steady-State Study.
    Feng L; Svarer C; Madsen K; Ziebell M; Dyssegaard A; Ettrup A; Hansen HD; Lehel S; Yndgaard S; Paulson OB; Knudsen GM; Pinborg LH
    Biomed Res Int; 2016; 2016():9132840. PubMed ID: 27123457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo.
    Malizia AL; Gunn RN; Wilson SJ; Waters SH; Bloomfield PM; Cunningham VJ; Nutt DJ
    Neuropharmacology; 1996; 35(9-10):1483-91. PubMed ID: 9014164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous in vivo measurements of receptor density and affinity using [11C]flumazenil and positron emission tomography: comparison of full saturation and steady state methods.
    Syvänen S; de Lange EC; Tagawa Y; Schenke M; Molthoff CF; Windhorst AD; Lammertsma AA; Voskuyl RA
    Neuroimage; 2011 Aug; 57(3):928-37. PubMed ID: 21609773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid feasibility studies of tracers for positron emission tomography: high-resolution PET in small animals with kinetic analysis.
    Ingvar M; Eriksson L; Rogers GA; Stone-Elander S; Widén L
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):926-31. PubMed ID: 1939386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands.
    Endres CJ; Carson RE
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1196-210. PubMed ID: 9809509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers.
    Lassen NA
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):709-16. PubMed ID: 1506439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms.
    Abi-Dargham A; Laruelle M; Seibyl J; Rattner Z; Baldwin RM; Zoghbi SS; Zea-Ponce Y; Bremner JD; Hyde TM; Charney DS
    J Nucl Med; 1994 Feb; 35(2):228-38. PubMed ID: 8294990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of the muscarinic acetylcholine neuroreceptor in rats with the M2 selective agonist [18F]FP-TZTP.
    Ravasi L; Tokugawa J; Nakayama T; Seidel J; Sokoloff L; Eckelman WC; Kiesewetter DO
    Nucl Med Biol; 2012 Jan; 39(1):45-55. PubMed ID: 21831648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-derived input function for [11C]flumazenil kinetic analysis in human brain.
    Sanabria-Bohórquez SM; Maes A; Dupont P; Bormans G; de Groot T; Coimbra A; Eng W; Laethem T; De Lepeleire I; Gambale J; Vega JM; Burns HD
    Mol Imaging Biol; 2003; 5(2):72-8. PubMed ID: 14499147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion.
    Eriksson O; Långström B; Josephsson R
    Ups J Med Sci; 2011 May; 116(2):100-6. PubMed ID: 21443419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.